Genome-wide Scan of 500 000 Single-Nucleotide Polymorphisms Among Responders and Nonresponders to Interferon Beta Therapy in Multiple SclerosisManuel Comabella, Xavier Montalbán, Arcadi Navarro et al.|Archives of Neurology|2009Cited by 114
Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide PolymorphismsManuel Comabella, Roland Martinꝉ, David W. Craig et al.|PLoS ONE|2008Cited by 105